Versifel CVR liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai kaķiem
Versifel CVR liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai kaķiem
Authorised
- Feline panleucopenia virus, strain Snow Leopard, Live
- Felid herpesvirus 1, strain FVRm, Live
- Feline calicivirus, strain F9, Live
Product identification
Medicine name:
Versifel CVR liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai kaķiem
Active substance:
- Feline panleucopenia virus, strain Snow Leopard, Live
- Felid herpesvirus 1, strain FVRm, Live
- Feline calicivirus, strain F9, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline panleucopenia virus, strain Snow Leopard, Live1000.00/50% cell culture infectious dose1.00unit(s)
-
Felid herpesvirus 1, strain FVRm, Live100000.00/50% cell culture infectious dose1.00unit(s)
-
Feline calicivirus, strain F9, Live316228.00/50% cell culture infectious dose1.00unit(s)
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Available in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/10/0014
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 15/12/2025